key: cord-0894281-lzpyi81c authors: Nguyen, Vi; Zhang, Yuping; Gao, Chao; Cao, Xiaoling; Tian, Yan; Carver, Wayne; Kiaris, Hippokratis; Cui, Taixing; Tan, Wenbin title: The Spike protein of SARS-CoV-2 impairs lipid metabolism and increases susceptibility to lipotoxicity: implication for a role of Nrf2 date: 2022-04-19 journal: bioRxiv DOI: 10.1101/2022.04.19.488806 sha: 617de212e8f7ff9fa3d9d708b0d900dc678c652c doc_id: 894281 cord_uid: lzpyi81c Background/objectives Coronavirus disease 2019 (COVID-19) patients exhibit lipid metabolic alterations, but the mechanism remains unknown. In this study, we aimed to investigate whether the Spike protein of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) impairs lipid metabolism in host cells. Methods A Spike cell line in HEK293 was generated using the pcDNA vector carrying the Spike gene expression cassette. A control cell line was generated using the empty pcDNA vector. Gene expression profiles related to lipid metabolic, autophagic, and ferroptotic pathways were investigated. Palmitic acid (PA)-overload was used to assess lipotoxicity-induced necrosis. Results As compared with controls, the Spike cells showed a significant increase in lipid depositions on cell membranes as well as dysregulation of expression of a panel of molecules involved lipid metabolism, autophagy, and ferroptosis. The Spike cells showed an upregulation of nuclear factor erythroid 2-related factor 2 (Nrf2), a multifunctional transcriptional factor, in response to PA. Furthermore, the Spike cells exhibited increased necrosis in response to PA-induced lipotoxicity compared to control cells in a time- and dose-dependent manner via ferroptosis, which could be attenuated by the Nrf2 inhibitor trigonelline. Conclusions The Spike protein impairs lipid metabolic and autophagic pathways in host cells, leading to increased susceptibility to lipotoxicity via ferroptosis which can be suppressed by a Nrf2 inhibitor. This data also suggests a central role of Nrf2 in Spike-induced lipid metabolic impairments. Highlights The Spike protein increases lipid deposition in host cell membranes The Spike protein impairs lipid metabolic and autophagic pathways The Spike protein exaggerates PA-induced lipotoxicity in host cells via ferroptosis Nrf2 inhibitor Trigonelline can mitigate the Spike protein-induced necrosis health since the initial outbreak in December 2019 at the epicenter of Wuhan City, Hubei Province, China. 1 COVID-19 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) with high pathogenicity and contagiousness. 2 SARS-CoV-2 is a positive-sense single-stranded RNA virus that is capable of infecting human beings, together with six other coronaviruses. 2 SARS-CoV-2 is assumed to be zoonotic and shares 96.3% sequence identity with the bat coronavirus RaTG13. 3 The SARS-COV2 Spike protein is thought to be the receptor for the virus entry into host cells via surface angiotensin converting enzyme 2 (ACE2). Cleavage of Spike protein by Furin and Transmembrane Serine Protease 2 (TMPRSS2) facilitates SARS-CoV-2 entry into host cells 4 . ACE2 and TMPRSS2 are thought to be host determinants during initial infection. 5 In addition, Neuropillin (NRP) 1 has been identified as the second host factor to facilitate SARS-CoV-2 entry upon cleavage by Furin. [6] [7] [8] COVID-19 patients can be asymptomatic or symptomatic. Mortality rate of the COVID-19 varies in different geographic locations and patient populations. 1 Patients with metabolicassociated preconditions such as hypertension, cardiovascular disorders (CVD), obesity and diabetes mellitus (DM) are susceptible to experience more severe symptoms. 9 One common pathogenic co-factor related to hypertension, obesity, DM and CVD is hypercholesterolemia. Emerging evidence reveals direct interplay between COVID-19 and dire cardiovascular complications including myocardial injury and heart failure that are accompanied by elevated risk and adverse outcomes among infected patients. 10 COVID-19-associated cardiac complications may become even worse in the setting of cardiometabolic pathologies associated with obesity, although obesity per se is a strong risk factor for severe COVID-19. 11 Our recent studies have shown decreased levels of total cholesterol (TC), low density lipoprotein cholesterol (LDL-c) and high density lipoprotein cholesterol (HDL-c) in COVID-19 patients, which are associated with disease severity and mortality. [12] [13] [14] Mechanistically, lipids have been shown to be a critical contributor to transmission, replication and transportation for some types of viruses. For example, lipid rafts have been reported to be necessary for SARS virus replication. 15 Although it has been firmly established that obesity and obesity-related complications are major risk factors for COVID-19 severity, the underlying mechanisms have yet to be determined. In this study, we attempted to explore the direct interplay between the Spike protein and lipid metabolism pathways in host cells. We found that the Spike protein impairs lipid metabolic and autophagic pathways in host cells, leading to increased susceptibility to lipotoxicity most likely via switching on nuclear factor erythroid 2-related factor 2 (Nrf2)mediated ferroptosis. Human embryonic kidney 293 cells (HEK293) and DMEM medium were purchased from ATCC (Manassas, VA, USA). Coding sequence of SARS-CoV-2 S gene (GenBank: QHU36824.1) fusion with a c-terminal His tag was synthesized in vitro (Genscript, Piscataway, NJ, USA) after an optimization for expression in human cells. 16 The sequence was cloned into a pcDNA3.1 vector to obtain pcDNA-Spike. 16 Anti-His tag and microtubule-associated protein 1 light chain 3 beta (LC3) Antibodies were purchased from Millipore Sigma (Burlington, MA, USA For immunoblot assay, cell lysates were extracted from HEK, HEK_pcDNA, or HEK_Spike cells using RIPA lysis buffer (Santa Cruz Biotech., Inc., Dallas, TX, USA). Proteins were separated by SDS-PAGE and transferred onto PVDF membranes. Primary antibodies were used to detect the expression of specific proteins and followed by HRP-labeled secondary antibodies. Images were acquired using a Bio-Rad Gel Imaging System (Hercules, CA, USA). The HEK293, HEK_pcDNA and HEK_Spike cells were cultured in a 96-well plate and reached 80% confluence on the next day before treatment. The cells were kept in DMEM medium with 5% The Spike gene was cleaved from pcDNA-Spike plasmid and cloned into lentiviral vector pLV-mCherry (Addgene, Watertown, MA, USA) with removal of mCherry gene to generate pLV-Spike plasmid. The lentiviral production followed our previous report with slight modifications. 16 We generated a Spike-pseudotyped (Spp) lentivirus with the Spike protein as the viral surface tropism as well as expression of the Spike protein, which was referred to as Cov-Spp-S virus. All statistical analysis were performed in Origin 2019. The student t test or one-way ANOVA was used for two groups or multiple comparisons test. The data was presented as "mean ± s.d." and p < 0.05 was considered as significant. The stable cell line with expression of the Spike protein was obtained upon neomycin selection after transfection of pcDNA_Spike into HEK293 cells. The control stable cell line with integration of the empty pcDNA was generated simultaneously. The expression of the Spike protein was verified using an anti-His tag antibody (Fig 1A) . The same pcDNA_Spike vector was used for production of the Spike protein-pseudotyped (Spp) lentivirus in HEK Phoenix cells in our previous study where the expression of the Spike protein was verified using both anti-Spike S1 and S2 subunit antibodies. 16 We did not observe a significant difference in growth rate between pcDNA and Spike stable cell lines (data not shown). To explore whether the Spike protein had a role in lipid metabolisms in host cells, we performed Oil Red O staining among these cell lines. We found there was a significant accumulation of lipid deposition in the Spike cells compared to pcDNA and mock control cells (Fig 1B) . The histological staining showed that the lipid depositions were mainly located on the cell membrane in the Spike cell line (Fig 1C-E) , indicating an impairment of lipid metabolism in host cells. We next examined transcriptional levels of a panel of 83 genes that are representative markers of lipid metabolism, autophagy, and ferroptosis (Supplementary Table 1 ). We found the mRNA levels of many lipid metabolic markers such as proprotein convertase subtilisin/kexin type 9 (Psck9), SREBF chaperone (Scap), Plin2, low density lipoprotein receptor-related protein 10 (Irp10), lecithin-cholesterol acyltransferase (lcat), low density lipoprotein receptor-related protein associated protein 1 (Irpap1), oxysterol binding protein-like 5 (Osbpl5), oxysterol binding protein-like 1A (Osbpl1a), protein kinase, AMP-activated, gamma 2 non-catalytic subunit (Prkag2), and mevalonate kinase (Mvk) were upregulated while Serpinb2 was downregulated in the Spike cells (Fig 2A) . For the examined autophagic and ferroptotic markers, Atg3, Atg7, Atg12, Nrf2, Phosphatidylinositol-4,5-Bisphosphate 3-Kinase Catalytic Subunit Alpha (Pik3ca), Pik3cd, Phosphoinositide-3-Kinase Regulatory Subunit 3 (Pik3r3), acyl-CoA synthetase longchain family 4 (Acsl4), ferritin heavy chain (Fth1), glutaminase 2 (Gls2), and Ptgs2 showed an increase in mRNA levels in the Spike cells; while Pik3c3, Atg5, and Hamp showed a decrease in mRNA levels in the Spike cells (Fig 2B, C) . These results reveal a negative impact of Spike proteins per se on lipid metabolism, autophagy, and probably ferroptosis in the cell. We further examined the biological significance of Spike protein expression with a focus on lipotoxicity in vitro. PA overload induced cell death in cultured HNK293 and pcDNA cells (Fig 3, Supplementary Fig 1) , demonstrating a PA-induced lipotoxicity as described elsewhere. 17 However, the PA-induced cell death was significantly augmented in Spike cells (Fig. 3 , Supplementary Fig. 1 ). The PA-induced cell death also showed a dose-and time-dependent response (Fig 3, Supplementary Fig 1) . The BSA control did not cause any significant cell death among these cell lines ( Supplementary Fig 2) . We next examined the expression patterns of some crucial factors in response to PA-induced lipotoxicity. SRB1, ATG7, PTGS2, showed a significantly higher level in the Spike cells than the mock and pcDNA control cells (Fig 4) , which were consistent with the changes in mRNA levels (Fig 2) . In response to PA treatment, the levels of SRB1, ATG7, PTGS2, LC3 I/II ratio, Fth1, in Spike cells increased significantly as compared with the pcDNA control cells (Fig 4) . We have previously shown that Nrf2 is the crucial transcriptional factor mediating PA-induced ferroptosis in autophagy-impaired in cardiomyocytes under obese conditions. 18 PI3K has been shown to play a critical role in autophagy. [19] [20] [21] We then asked whether inhibitors for Nrf2, PI3K, and ferroptosis could attenuate PA-induced lipotoxicity in the Spike cells. Indeed, the Nrf2 inhibitor TRG, PI3K pan inhibitor Wortmannin, and ferroptosis inhibitor ferrostatin, but not a necroptosis inhibitor necrostatin 1, significantly mitigated the PA-induced Spike proteinexaggerated lipotoxicity (Fig 5) . Finally, we attempted to test whether a similar mechanism could be recapitulated in H9C2 cells, a cardiomyocyte-like cell line. We infected the H9C2 cells using CoV-Spp-S lentivirus expressing the Spike protein or VSV-G control virus expressing mCherry. The cells infected by the CoV-Spp-S showed a significantly higher cell death than the cells being infected by the VSV-G control virus (Supplementary Fig 3) ; the PA-induced Spike protein-exaggerated lipotoxicity could be reversed using the Nrf2 inhibitor TRG (Supplementary Fig 3) . The There are several questions yet to be answered, which will be the focus of our future studies. COVID-19 Dashboard by the The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 A pneumonia outbreak associated with a new coronavirus of probable bat origin Structure, Function, and Antigenicity of the SARS-CoV-2 Spike Glycoprotein SARS-CoV-2 receptor ACE2 is an interferon-stimulated gene in human airway epithelial cells and is enriched in specific cell subsets across tissues Neuropilin-1 is a host factor for SARS-CoV-2 infection Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity SARS-CoV-2 Spike protein co-opts VEGF-A/Neuropilin-1 receptor signaling to induce analgesia Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area Cardiovascular Complications Associated with COVID-19 and Potential Therapeutic~Strategies Global pandemics interconnectedobesity, impaired metabolic health and COVID-19 Low-density lipoprotein is a potential predictor of poor prognosis in patients with coronavirus disease 2019 Hypolipidemia is associated with the severity of COVID-19 Cholesterol: A new game player accelerating endothelial injuries caused by SARS-CoV-2? Lipid rafts are involved in SARS-CoV entry into Vero E6 cells Spike protein of SARS-CoV-2 activates macrophages and contributes to induction of acute lung inflammation in male mice Lipid-induced NOX2 activation inhibits autophagic flux by impairing lysosomal enzyme activity The Dark Side of Nrf2 in the Heart Cellular entry of human papillomavirus type 16 involves activation of the phosphatidylinositol 3-kinase/Akt/mTOR pathway and inhibition of autophagy Recruitment of Vps34 PI3K and enrichment of PI3P phosphoinositide in the viral replication compartment is crucial for replication of a positive-strand RNA virus Class III PI3K Vps34 plays an essential role in autophagy and in heart and liver function Proteomic and Metabolomic Characterization of COVID-19 Omics-Driven Systems Interrogation of Metabolic Dysregulation in COVID-19 Pathogenesis Cutting Edge: Severe SARS-CoV-2 Infection in Humans Is Defined by a Shift in the Serum Lipidome, Resulting in Dysregulation of Eicosanoid Immune Mediators Plasma metabolomic and lipidomic alterations associated with COVID-19 Large-Scale Plasma Analysis Revealed New Mechanisms and Molecules Associated with the Host Response to SARS-CoV-2 Dissecting lipid metabolism alterations in SARS-CoV-2 Follow-up study on serum cholesterol profiles and potential sequelae in recovered COVID-19 patients Growth Factor Receptor Signaling Inhibition Prevents SARS-CoV-2 Suppression of SARS-CoV-2 infection in ex-vivo human lung tissues by targeting class III phosphoinositide 3-kinase Defects of Vps15 in skeletal muscles lead to autophagic vacuolar myopathy and lysosomal disease Nrf2-Mediated Cardiac Maladaptive Remodeling and Dysfunction in a Setting of Autophagy Insufficiency Autophagy Inhibition Enables Nrf2 to Exaggerate the Progression of Diabetic Cardiomyopathy in Mice Autophagy and mitophagy in diabetic cardiomyopathy The interplay between autophagy and apoptosis in the diabetic heart We greatly appreciate Dr. Mitzi Nagarkatti from the Department of Pathology, Microbiology and